Diabetic gastroparesis
Conditions
Interventions
Shejiu Treatment Group:Utilizing the Congjing Shejiu Device (CJ1003-I series)
Control Group:Utilizing a shejiu device without ultrashort wave and thermal effects
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age >=18 years and 50%; 4. Exclusion of other causes: rule out mechanical obstruction, drug-induced causes (such as opioids, GLP-1 receptor agonists), or neurological diseases (such as Parkinson's disease) leading to gastric motility disorders; 5. Sign informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnancy; 2. Presence of gastric outlet obstruction; 3. Peptic ulcer, gastroesophageal reflux disease, digestive system tumors, or known diseases affecting gastric emptying, or history of gastrointestinal surgery; 4. Use of a-glucosidase inhibitors, opioid drugs, or anticholinergic drugs within the past 2 weeks; 5. Concurrent acute diabetic complications such as hyperosmolar hyperglycemic state, diabetic ketoacidosis, or severe liver dysfunction (transaminases over 2 times the normal value), severe renal impairment (eGFR <45 ml/min/1.73 m^2); 6. Contraindicated in patients with epilepsy, malignant tumors, bleeding tendencies, active tuberculosis, pregnancy, local metallic foreign bodies, implanted electronic devices such as pacemakers, increased intracranial pressure, glaucoma, and insensitivity to heat.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-hour gastric retention rate;Half-emptying time (T1/2);The weighted score (GCSI × 1.33 + GSRS × 0.8) ; | — |
Countries
China
Contacts
Public ContactQi Pan
Beijing Hospital
Outcome results
None listed